(1->4)-beta-D-glucan multiple interactions ISO RGD:62171 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PSMB5 mRNA CTD PMID:36331819 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:62171 6480464 o, p'-DDT results in increased expression of PSMB5 mRNA CTD PMID:24096037 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o, p'-DDT results in increased expression of PSMB5 mRNA CTD PMID:24096037 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression EXP 6480464 o, p'-DDT affects the expression of PSMB5 mRNA CTD PMID:17984292 1,3-dinitrobenzene affects expression EXP 6480464 3-dinitrobenzene affects the expression of PSMB5 mRNA CTD PMID:16988215 17alpha-ethynylestradiol affects expression ISO RGD:62171 6480464 Ethinyl Estradiol affects the expression of PSMB5 mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of PSMB5 mRNA CTD PMID:16174780 more ... 17alpha-ethynylestradiol increases expression ISO RGD:62171 6480464 Ethinyl Estradiol results in increased expression of PSMB5 mRNA CTD PMID:16174780 more ... 17alpha-ethynylestradiol multiple interactions ISO RGD:62171 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PSMB5 mRNA CTD PMID:17942748 17beta-estradiol affects expression ISO RGD:62171 6480464 Estradiol affects the expression of PSMB5 mRNA CTD PMID:15598610 1H-pyrazole increases expression ISO RGD:62171 6480464 pyrazole results in increased expression of PSMB5 mRNA CTD PMID:17945193 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO RGD:62171 6480464 troxerutin inhibits the reaction [2 more ... CTD PMID:25639565 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:62171 6480464 2 more ... CTD PMID:25639565 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:62171 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of PSMB5 mRNA, [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PSMB5 mRNA CTD PMID:16214954 , PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PSMB5 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:62171 6480464 Tetrachlorodibenzodioxin affects the expression of PSMB5 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:62171 6480464 Tetrachlorodibenzodioxin results in increased expression of PSMB5 mRNA CTD PMID:17942748 , PMID:18796159 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:62171 6480464 Tetrachlorodibenzodioxin results in decreased expression of PSMB5 mRNA CTD PMID:16723119 2,4,6-trinitrotoluene affects expression EXP 6480464 Trinitrotoluene affects the expression of PSMB5 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of PSMB5 mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO RGD:735704 6480464 Lactic Acid results in decreased expression of PSMB5 mRNA CTD PMID:30851411 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of PSMB5 mRNA CTD PMID:15890375 3-methylcholanthrene increases activity ISO RGD:62171 6480464 Methylcholanthrene results in increased activity of PSMB5 protein CTD PMID:16723119 3-methylcholanthrene multiple interactions ISO RGD:62171 6480464 NFE2L2 protein affects the reaction [Methylcholanthrene results in increased expression of PSMB5 mRNA] CTD PMID:16723119 3-methylcholanthrene increases expression ISO RGD:62171 6480464 Methylcholanthrene results in increased expression of PSMB5 mRNA, Methylcholanthrene results in increased expression of PSMB5 protein CTD PMID:16723119 3H-1,2-dithiole-3-thione increases expression ISO RGD:62171 6480464 1, 2-dithiol-3-thione results in increased expression of PSMB5 mRNA CTD PMID:15375163 , PMID:22959925 3H-1,2-dithiole-3-thione increases activity ISO RGD:62171 6480464 1, 2-dithiol-3-thione results in increased activity of PSMB5 protein CTD PMID:22959925 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PSMB5 mRNA CTD PMID:36041667 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PSMB5 mRNA CTD PMID:15890375 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of PSMB5 mRNA CTD PMID:15890375 aldehydo-D-glucose increases secretion ISO RGD:735704 6480464 Glucose deficiency results in increased secretion of PSMB5 protein CTD PMID:24802182 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PSMB5 mRNA CTD PMID:16483693 aristolochic acid A increases expression ISO RGD:735704 6480464 aristolochic acid I results in increased expression of PSMB5 mRNA, aristolochic acid I results in increased expression of PSMB5 protein CTD PMID:33212167 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of PSMB5 mRNA CTD PMID:18178546 arsenite(3-) multiple interactions ISO RGD:735704 6480464 arsenite promotes the reaction [G3BP1 protein binds to PSMB5 mRNA] CTD PMID:32406909 astemizole increases expression EXP 6480464 Astemizole results in increased expression of PSMB5 mRNA CTD PMID:20221588 atrazine increases expression ISO RGD:735704 6480464 Atrazine results in increased expression of PSMB5 mRNA CTD PMID:22378314 benzo[a]pyrene increases expression ISO RGD:62171 6480464 Benzo(a)pyrene results in increased expression of PSMB5 mRNA CTD PMID:22228805 beta-naphthoflavone increases activity ISO RGD:62171 6480464 beta-Naphthoflavone results in increased activity of PSMB5 protein CTD PMID:16723119 beta-naphthoflavone increases expression ISO RGD:62171 6480464 beta-Naphthoflavone results in increased expression of PSMB5 protein CTD PMID:16723119 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of PSMB5 mRNA CTD PMID:21318169 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PSMB5 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PSMB5 mRNA CTD PMID:36041667 bisphenol A decreases expression ISO RGD:735704 6480464 bisphenol A results in decreased expression of PSMB5 protein CTD PMID:34186270 bisphenol A increases expression ISO RGD:62171 6480464 bisphenol A results in increased expression of PSMB5 mRNA CTD PMID:33221593 Bisphenol B increases expression ISO RGD:735704 6480464 bisphenol B results in increased expression of PSMB5 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:735704 6480464 bisphenol F results in increased expression of PSMB5 protein CTD PMID:34186270 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PSMB5 mRNA CTD PMID:36041667 bortezomib affects binding ISO RGD:735704 6480464 Bortezomib binds to PSMB5 protein CTD PMID:22216088 bortezomib affects response to substance ISO RGD:735704 6480464 PSMB5 protein affects the susceptibility to Bortezomib CTD PMID:22216088 bortezomib increases expression EXP 6480464 Bortezomib results in increased expression of PSMB5 mRNA CTD PMID:20213465 bortezomib decreases response to substance ISO RGD:735704 6480464 PSMB5 gene mutant form results in decreased susceptibility to Bortezomib CTD PMID:22216088 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of PSMB5 mRNA CTD PMID:12628495 butane-2,3-dione increases expression ISO RGD:735704 6480464 Diacetyl results in increased expression of PSMB5 protein CTD PMID:34031698 cannabidiol multiple interactions ISO RGD:735704 6480464 [Cuprizone co-treated with Cannabidiol] results in decreased expression of PSMB5 protein CTD PMID:34122009 carbon nanotube increases expression ISO RGD:62171 6480464 Nanotubes more ... CTD PMID:25554681 chloropicrin affects expression ISO RGD:735704 6480464 chloropicrin affects the expression of PSMB5 mRNA CTD PMID:26352163 chlorpyrifos increases expression ISO RGD:62171 6480464 Chlorpyrifos results in increased expression of PSMB5 mRNA CTD PMID:37019170 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of PSMB5 protein CTD PMID:34058248 clobetasol increases expression ISO RGD:62171 6480464 Clobetasol results in increased expression of PSMB5 mRNA CTD PMID:27462272 clofibrate multiple interactions ISO RGD:62171 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of PSMB5 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PSMB5 mRNA] CTD PMID:17585979 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of PSMB5 mRNA CTD PMID:21318169 clofibrate decreases expression ISO RGD:62171 6480464 Clofibrate results in decreased expression of PSMB5 mRNA CTD PMID:17585979 clozapine multiple interactions ISO RGD:735704 6480464 [Cuprizone co-treated with Clozapine] results in increased expression of PSMB5 protein CTD PMID:34122009 Cuprizon multiple interactions ISO RGD:735704 6480464 [Cuprizone co-treated with Cannabidiol] results in decreased expression of PSMB5 protein, [Cuprizone co-treated with Clozapine] results in increased expression of PSMB5 protein CTD PMID:34122009 cypermethrin increases expression ISO RGD:62171 6480464 cypermethrin results in increased expression of PSMB5 mRNA CTD PMID:21142847 D-glucose increases secretion ISO RGD:735704 6480464 Glucose deficiency results in increased secretion of PSMB5 protein CTD PMID:24802182 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of PSMB5 mRNA CTD PMID:23914054 dibutyl phthalate decreases expression ISO RGD:62171 6480464 Dibutyl Phthalate results in decreased expression of PSMB5 mRNA CTD PMID:17361019 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of PSMB5 mRNA CTD PMID:15890375 doxorubicin decreases expression ISO RGD:62171 6480464 Doxorubicin results in decreased expression of PSMB5 mRNA CTD PMID:27155237 doxorubicin increases expression ISO RGD:735704 6480464 Doxorubicin results in increased expression of PSMB5 mRNA CTD PMID:29803840 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of PSMB5 mRNA CTD PMID:29391264 fenvalerate decreases expression EXP 6480464 fenvalerate results in decreased expression of PSMB5 protein CTD PMID:33656234 finasteride increases expression EXP 6480464 Finasteride results in increased expression of PSMB5 mRNA CTD PMID:24136188 flutamide increases expression EXP 6480464 Flutamide results in increased expression of PSMB5 mRNA CTD PMID:24136188 furan increases methylation EXP 6480464 furan results in increased methylation of PSMB5 gene CTD PMID:22079235 glucose increases secretion ISO RGD:735704 6480464 Glucose deficiency results in increased secretion of PSMB5 protein CTD PMID:24802182 glyphosate increases expression ISO RGD:62171 6480464 glyphosate results in increased expression of PSMB5 protein CTD PMID:36173347 heparin decreases activity ISO RGD:735704 6480464 Heparin analog results in decreased activity of PSMB5 protein CTD PMID:26476401 heparin decreases expression ISO RGD:735704 6480464 Heparin analog results in decreased expression of PSMB5 mRNA CTD PMID:26476401 hydrogen peroxide multiple interactions ISO RGD:62171 6480464 Hydrogen Peroxide promotes the reaction [NFE2L2 protein binds to PSMB5 promoter] CTD PMID:22308036 hydrogen peroxide increases expression ISO RGD:62171 6480464 Hydrogen Peroxide results in increased expression of PSMB5 mRNA CTD PMID:22308036 inulin multiple interactions ISO RGD:62171 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PSMB5 mRNA CTD PMID:36331819 isoprenaline multiple interactions EXP 6480464 [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMB5 mRNA CTD PMID:30303030 isotretinoin decreases expression ISO RGD:735704 6480464 Isotretinoin results in decreased expression of PSMB5 mRNA CTD PMID:20436886 ivermectin decreases expression ISO RGD:735704 6480464 Ivermectin results in decreased expression of PSMB5 protein CTD PMID:32959892 lipopolysaccharide increases expression ISO RGD:62171 6480464 Lipopolysaccharides results in increased expression of PSMB5 mRNA CTD PMID:19339665 lipopolysaccharide multiple interactions ISO RGD:62171 6480464 methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased expression of PSMB5 mRNA] CTD PMID:19339665 metam multiple interactions ISO RGD:62171 6480464 methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased expression of PSMB5 mRNA] CTD PMID:19339665 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of PSMB5 mRNA CTD PMID:15890375 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of PSMB5 mRNA CTD PMID:28659758 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:62171 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PSMB5 mRNA CTD PMID:15525353 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO RGD:735704 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of PSMB5 mRNA, benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of PSMB5 protein CTD PMID:32301004 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:735704 6480464 [sodium arsenite co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] results in decreased expression of PSMB5 mRNA more ... CTD PMID:32301004 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:735704 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PSMB5 mRNA CTD PMID:31806706 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of PSMB5 mRNA CTD PMID:15890375 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of PSMB5 mRNA CTD PMID:24136188 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of PSMB5 mRNA CTD PMID:24136188 ozone increases expression ISO RGD:735704 6480464 Ozone results in increased expression of PSMB5 mRNA CTD PMID:23033980 paracetamol multiple interactions ISO RGD:62171 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of PSMB5 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PSMB5 mRNA] CTD PMID:17585979 paraquat multiple interactions ISO RGD:62171 6480464 PARK7 gene mutant form affects the reaction [Paraquat affects the expression of PSMB5 protein] CTD PMID:17823202 pentachlorophenol increases expression ISO RGD:62171 6480464 Pentachlorophenol results in increased expression of PSMB5 mRNA CTD PMID:23892564 perfluorooctane-1-sulfonic acid affects expression ISO RGD:62171 6480464 perfluorooctane sulfonic acid affects the expression of PSMB5 mRNA CTD PMID:19429403 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:62171 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PSMB5 mRNA more ... CTD PMID:20936131 , PMID:36331819 perfluorooctane-1-sulfonic acid increases expression ISO RGD:62171 6480464 perfluorooctane sulfonic acid results in increased expression of PSMB5 mRNA CTD PMID:20936131 perfluorooctanoic acid affects expression ISO RGD:62171 6480464 perfluorooctanoic acid affects the expression of PSMB5 mRNA CTD PMID:19429403 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of PSMB5 mRNA, perfluorooctanoic acid results in increased expression of PSMB5 protein CTD PMID:19162173 more ... perfluorooctanoic acid multiple interactions ISO RGD:62171 6480464 PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of PSMB5 mRNA] CTD PMID:18467677 perfluorooctanoic acid increases expression ISO RGD:62171 6480464 perfluorooctanoic acid results in increased expression of PSMB5 mRNA CTD PMID:18467677 permethrin multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of PSMB5 mRNA CTD PMID:28659758 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of PSMB5 mRNA CTD PMID:19162173 , PMID:21318169 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of PSMB5 mRNA CTD PMID:15890375 , PMID:22484513 pirinixic acid multiple interactions ISO RGD:62171 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of PSMB5 mRNA] CTD PMID:17950772 , PMID:20059764 pirinixic acid increases expression ISO RGD:62171 6480464 pirinixic acid results in increased expression of PSMB5 mRNA CTD PMID:15375163 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of PSMB5 mRNA CTD PMID:15890375 more ... pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of PSMB5 mRNA CTD PMID:19162173 , PMID:21318169 Pyridostigmine bromide multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of PSMB5 mRNA CTD PMID:28659758 rac-lactic acid decreases expression ISO RGD:735704 6480464 Lactic Acid results in decreased expression of PSMB5 mRNA CTD PMID:30851411 resveratrol multiple interactions ISO RGD:735704 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of PSMB5 mRNA, PSMB5 protein affects the reaction [Resveratrol results in decreased secretion of APP protein] CTD PMID:16162502 , PMID:23557933 resveratrol decreases expression ISO RGD:62171 6480464 resveratrol results in decreased expression of PSMB5 protein CTD PMID:25505154 resveratrol decreases expression ISO RGD:735704 6480464 resveratrol results in decreased expression of PSMB5 protein CTD PMID:24627483 ritonavir increases expression EXP 6480464 Ritonavir results in increased expression of PSMB5 mRNA CTD PMID:20213465 rotenone decreases expression ISO RGD:62171 6480464 Rotenone results in decreased expression of PSMB5 mRNA CTD PMID:23186747 sibutramine decreases expression ISO RGD:735704 6480464 sibutramine results in decreased expression of PSMB5 protein CTD PMID:27838152 sodium arsenite affects expression ISO RGD:735704 6480464 sodium arsenite affects the expression of PSMB5 mRNA CTD PMID:29319823 sodium arsenite decreases expression ISO RGD:735704 6480464 sodium arsenite results in decreased expression of PSMB5 protein CTD PMID:32301004 sodium arsenite affects response to substance ISO RGD:735704 6480464 PSMB5 protein affects the susceptibility to sodium arsenite CTD PMID:32301004 sodium arsenite multiple interactions ISO RGD:735704 6480464 [PSMB5 protein affects the susceptibility to sodium arsenite] which results in decreased expression of GPX1 mRNA more ... CTD PMID:32301004 sodium arsenite increases expression ISO RGD:735704 6480464 sodium arsenite results in increased expression of PSMB5 mRNA CTD PMID:32301004 , PMID:34032870 stattic decreases expression ISO RGD:735704 6480464 stattic results in decreased expression of PSMB5 mRNA, stattic results in decreased expression of PSMB5 protein CTD PMID:24627483 stattic multiple interactions ISO RGD:735704 6480464 stattic inhibits the reaction [EGF protein results in increased expression of PSMB5 protein] CTD PMID:24627483 sulindac increases expression EXP 6480464 Sulindac results in increased expression of PSMB5 mRNA CTD PMID:24136188 tamoxifen affects expression ISO RGD:62171 6480464 Tamoxifen affects the expression of PSMB5 mRNA CTD PMID:17555576 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of PSMB5 mRNA CTD PMID:19400957 tamoxifen increases expression ISO RGD:62171 6480464 Tamoxifen results in increased expression of PSMB5 mRNA CTD PMID:19400957 Tanshinone I increases expression ISO RGD:735704 6480464 tanshinone results in increased expression of PSMB5 mRNA CTD PMID:15849732 theophylline affects expression EXP 6480464 Theophylline affects the expression of PSMB5 mRNA CTD PMID:16988215 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of PSMB5 mRNA CTD PMID:14565619 tunicamycin increases expression ISO RGD:62171 6480464 Tunicamycin results in increased expression of PSMB5 mRNA CTD PMID:22959925 tunicamycin multiple interactions ISO RGD:62171 6480464 NFE2L2 mRNA affects the reaction [Tunicamycin results in increased expression of PSMB5 mRNA] CTD PMID:22959925 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of PSMB5 mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:62171 6480464 Valproic Acid affects the expression of PSMB5 mRNA CTD PMID:17963808 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of PSMB5 mRNA CTD PMID:21318169 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of PSMB5 mRNA CTD PMID:23034163 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of PSMB5 gene CTD PMID:31682807 vitamin E increases expression ISO RGD:735704 6480464 Vitamin E results in increased expression of PSMB5 mRNA CTD PMID:19244175